European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)

Affiliations

• ¹ GenQA, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
• ² Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
• ³ MLL-Munich Leukemia Laboratory, Munich, Germany.
• ⁴ Department of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
• ⁵ Hematopathology Section, Hospital Clinic, Barcelona, Spain.
• ⁶ Laboratori de Citogenètica Molecular, Servei de Patologia, Grup de Recerca, Translacional en Neoplàsies Hematològiques, Cancer Research Program, imim-Hospital del Mar, Barcelona, Spain.
• ⁷ Viapath Genetics Laboratories, Guys Hospital, London, UK.
• ⁸ West Midlands Regional Genetics Laboratory, Birmingham Women's Hospital, Birmingham, UK.
• ⁹ Department of Cytogenetics, Nottingham University Hospital, Nottingham, UK.
• ¹⁰ Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.
• ¹¹ Oncogénomique laboratory, Hematology Department, Lausanne University Hospital, Vaudois, Switzerland.
• ¹² Oncology Cytogenetics Service, The Christie NHS Foundation Trust, Manchester, UK.
• ¹³ Laboratorio di Citogenetica e genetica moleculaire, Laboratorio Analisi, Humanitas Research Hospital, Rozzano, Milan, Italy.
• ¹⁴ Center of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
• ¹⁵ GenQA, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK. Ros.Hastings@ouh.nhs.uk.